Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19553756 | 0.86 | CA1 (0.35) | MAPTLMNA | |
| SCHEMBL28520119 | 0.85 | MAPT (0.49) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL27734730 | 0.84 | MAPT (0.51) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL5365642 | 0.84 | MAPT (0.51) | MAPTLMNAKDM4EDUSP3MEN1 | |
| Octane SCHEMBL4338103 | 0.82 | CA1 (0.40) | MAPTLPAR1LPAR4LPAR2LPAR3 | |
| SCHEMBL27603184 | 0.82 | MAPT (0.50) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL27496716 | 0.80 | MAPT (0.53) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL27952502 | 0.78 | MAPT (0.56) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL9579019 | 0.73 | LMNA (0.50) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL20504493 | 0.72 | MAPT (0.42) | MAPTLMNAKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10918618-B2 | Methods of reducing microbial contamination | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-02-16 | — | — | US | disclosed |
| EP-2497459-B1 | Methods of reducing microbial contamination | 3M INNOVATIVE PROPERTIES CO (US) | 2019-04-24 | — | — | EP | disclosed |
| EP-3025704-B1 | METHODS OF REDUCING MICROBIAL CONTAMINATION | 3M INNOVATIVE PROPERTIES CO (US) | 2019-01-16 | — | — | EP | disclosed |
| US-20180207122-A1 | METHODS OF REDUCING MICROBIAL CONTAMINATION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-07-26 | — | — | US | disclosed |
| EP-3025704-A1 | METHODS OF REDUCING MICROBIAL CONTAMINATION | 3M Innovative Properties Company (US) | 2016-06-01 | — | — | EP | disclosed |
| US-20150094368-A1 | METHODS OF REDUCING MICROBIAL CONTAMINATION | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2015-04-02 | — | — | US | disclosed |
| EP-1858482-B1 | METHODS OF REDUCING MICROBIAL CONTAMINATION | 3M INNOVATIVE PROPERTIES CO (US) | 2014-04-23 | — | — | EP | disclosed |
| EP-2497459-A1 | Methods of reducing microbial contamination | 3M Innovative Properties Co. (US) | 2012-09-12 | — | — | EP | disclosed |
| EP-2497460-A1 | Methods of reducing microbial contamination | 3M Innovative Properties Co. (US) | 2012-09-12 | — | — | EP | disclosed |
| US-20090226541-A1 | METHODS OF REDUCING MICROBIAL CONTAMINATION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-09-10 | — | — | US | disclosed |
| EP-1858482-A2 | METHODS OF REDUCING MICROBIAL CONTAMINATION | 3M Innovative Properties Company (US) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006099359-A2 | METHODS OF REDUCING MICROBIAL CONTAMINATION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10918618-B2 | Methods of reducing microbial contamination | LPO, CAT, UNG | MAPT 3852/4885LMNA 2073/4885KDM4E 4241/4885 |
| US-20150094368-A1 | METHODS OF REDUCING MICROBIAL CONTAMINATION | LPO, CAT, UNG | MAPT 3852/4885LMNA 2073/4885KDM4E 4241/4885 |
| US-20090226541-A1 | METHODS OF REDUCING MICROBIAL CONTAMINATION | LPO, CAT, UNG | MAPT 3852/4885LMNA 2073/4885KDM4E 4241/4885 |
| US-20180207122-A1 | METHODS OF REDUCING MICROBIAL CONTAMINATION | LPO, CAT, UNG | MAPT 3852/4885LMNA 2073/4885KDM4E 4241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.